Background The diffuse nature of cardiac allograft vasculopathy makes early detection of the disease by traditional noninvasive methods or coronary angiography difficult. The aim of this study was to determine if there is a relation between abnormalities in vessel wall morphology, as assessed by intracoronary ultrasound, and a decreased vasodilatory response to the endothelium-dependent vasodilator papaverine hydrochloride and if cardiac allograft vasculopathy detected by coronary angiography is associated with specific intracoronary ultrasound findings.
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Methods and Results Twenty-three heart transplant recipients underwent 25 intracoronary ultrasound studies and 24 studies of coronary vasomotor tone 10 days to 8.3 years after surgery using a 20-mHz intracoronary ultrasound catheter. The studies were divided in two groups according to the presence (n=7, group 1) or absence (n= 18, group 2) of angiographically evident cardiac allograft vasculopathy. Qualitative assessment of vessel wall morphology and quantitative analysis of the vasodilator response to the injection of papaverine hydrochloride into the coronary artery distal to the imaging site were performed off-line, and results for the two study groups were compared. A significantly higher percentage T nhe diffuse nature of cardiac allograft vasculopathy makes early detection of the disease with noninvasive methods' or coronary angiography2 difficult. Pathological evidence of cardiac allograft vasculopathy has been found in the absence of angiographically demonstrable disease.4 Intracoronary ultrasound imaging has been shown recently to detect vessel wall abnormalities even when the coronary arteries are angiographically normal.S However, it has not been conclusively shown that the three-interface vessel wall morphology on intracoronary ultrasound imaging ( After baseline images were recorded, papaverine hydrochloride (7.5 mg) was administered through the central lumen of the intracoronary ultrasound catheter, distal to the imaging site, to evaluate flow-dependent rather than local papaverineinduced vasodilatation. Ultrasound images of papaverineinduced changes in vessel size were continuously recorded.
After return to baseline dimension, 200 artery disease suggests that vascular responses to papaverine are not influenced by denervation. Vascular responses to acetylcholine, another endothelium-dependent vasodilator, have been shown to be abnormal early9 and late'9 after transplantation even in the absence of angiographic cardiac allograft vasculopathy, perhaps reflecting the presence of endothelial damage and not necessarily that of cardiac allograft vasculopathy. 20 In contrast, in our previous study done early after heart transplantation,2' vasodilatation of the coronary arteries in response to papaverine was uniformly normal and similar to that reported by other investigators in nontransplant patients with normal coronary arteries. 8 In this study, the degree of papaverine-induced vasodilatation was significantly less in patients with than in those without angiographic evidence of cardiac allograft vasculopathy. In native atherosclerotic coronary arteries that vasoconstricted in response to acetylcholine, flow-mediated vasodilatation was preserved.22 The differential ability of papaverine and acetylcholine to identify patients with and without cardiac allograft vasculopathy may be due to the fact that these two endothelium-dependent vasodilators produce their vascular effects by means of distinct intermediate mediators. Muscarinic receptors on the endothelium may also be more sensitive to ischemic, immunologic, and other insults after transplantation. Thus, flow-mediated vasodilatation induced by papaverine may be more specific to detect cardiac allograft vasculopathy rather than changes due to endothelial abnormalities other than cardiac allograft vasculopathy.
The vasodilatation produced by papaverine is independent of flow within 30 seconds of injection and later becomes flow dependent.23 Because in our study the greatest changes in allograft coronary luminal size oc- papaverine-induced vasodilatation probably is due to increased flow. Interestingly, flow-mediated coronary vasodilatation in one recipient without cardiac allograft vasculopathy but with three interfaces on intracoronary ultrasound demonstrated a blunted response to intracoronary papaverine similar to that observed in recipients with angiographic cardiac allograft vasculopathy. This finding suggests that the appearance of three interfaces on intracoronary ultrasound and a blunted vasodilatory response to papaverine may allow earlier detection of cardiac allograft vasculopathy than coronary angiography. These data are preliminary, and serial studies in a larger number of patients are in progress.
Vascular luminal cross-sectional area may more accurately evaluate vessel luminal dimension than diameter because diameter may not accurately reflect vessel size in the presence of luminal eccentricity.24 This may explain the clearer demonstration of the difference in flow-mediated vasodilatation, in both absolute and relative terms, with cross-sectional area rather than with diameter measurements.
Simultaneous flow measurements were not performed because of the technical limitations of our equipment. However, continuous on-line intracoronary ultrasound monitoring, done to detect the maximal response to papaverine, may have compensated at least partially for this limitation. Retrograde flow of papaverine proximal to the imaging site was unlikely because the intracoronary ultrasound catheter did not obstruct [ Anglographic CAV Our study is limited by the small patient population, the paucity of serial studies, the lack of direct measurements of flow, and the lack of gating of cardiac cycles. However, despite its limitations, our study shows a significant association between the morphological appearance and functional abnormalities of allograft coronary arteries. The combined use of intracoronary ultrasound to evaluate vessel wall morphology and flow-mediated vascular responses to papaverine may allow identification of cardiac allograft vasculopathy before it becomes angiographically apparent. Studies evaluating the diagnostic accuracy of this approach are in progress.
